Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Ciriello G, Gatza ML, Beck AH, Wilkerson MD, Rhie SK, Pastore A, Zhang H, McLellan M, Yau C, Kandoth C, Bowlby R, Shen H, Hayat S, Fieldhouse R, Lester SC, Tse GM, Factor RE, Collins LC, Allison KH, Chen YY, Jensen K, Johnson NB, Oesterreich S, Mills GB, Cherniack AD, Robertson G, Benz C, Sander C, Laird PW, Hoadley KA, King TA, TCGA Research Network, Perou CM (2015) Cell 163: 506-19 The collagen receptor discoidin domain receptor 2 stabilizes SNAIL1 to facilitate breast cancer metastasis. Zhang K, Corsa CA, Ponik SM, Prior JL, Piwnica-Worms D, Eliceiri KW, Keely PJ, Longmore GD (2013) Nat Cell Biol 15: 677-87 When and to what end do pathologists agree? Page DL, Dupont WD, Jensen RA, Simpson JF (1998) J Natl Cancer Inst 90: 88-9 Transforming growth factor-beta and breast cancer risk in women with mammary epithelial hyperplasia. Gobbi H, Dupont WD, Simpson JF, Plummer WD, Schuyler PA, Olson SJ, Arteaga CL, Page DL (1999) J Natl Cancer Inst 91: 2096-101 Identification of p62/SQSTM1 as a component of non-canonical Wnt VANGL2-JNK signalling in breast cancer. Puvirajesinghe TM, Bertucci F, Jain A, Scerbo P, Belotti E, Audebert S, Sebbagh M, Lopez M, Brech A, Finetti P, Charafe-Jauffret E, Chaffanet M, Castellano R, Restouin A, Marchetto S, Collette Y, Gonçalvès A, Macara I, Birnbaum D, Kodjabachian L, Johansen T, Borg JP (2016) Nat Commun 7: 10318 An HLA-presented fragment of macrophage migration inhibitory factor is a therapeutic target for invasive breast cancer. Hawkins O, Verma B, Lightfoot S, Jain R, Rawat A, McNair S, Caseltine S, Mojsilovic A, Gupta P, Neethling F, Almanza O, Dooley W, Hildebrand W, Weidanz J (2011) J Immunol 186: 6607-16 Histologic associations and long-term cancer risk in columnar cell lesions of the breast: a retrospective cohort and a nested case-control study. Boulos FI, Dupont WD, Simpson JF, Schuyler PA, Sanders ME, Freudenthal ME, Page DL (2008) Cancer 113: 2415-21 Understanding the relationship between relative and absolute risk. Dupont WD, Plummer WD (1996) Cancer 77: 2193-9 Continued local recurrence of carcinoma 15-25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy. Page DL, Dupont WD, Rogers LW, Jensen RA, Schuyler PA (1995) Cancer 76: 1197-200 Heterogeneous expression of nm23 gene product in noninvasive breast carcinoma. Simpson JF, O'Malley F, Dupont WD, Page DL (1994) Cancer 73: 2352-8 Magnetic resonance imaging as a predictor of pathologic response in patients treated with neoadjuvant systemic treatment for operable breast cancer. Translational Breast Cancer Research Consortium trial 017. De Los Santos JF, Cantor A, Amos KD, Forero A, Golshan M, Horton JK, Hudis CA, Hylton NM, McGuire K, Meric-Bernstam F, Meszoely IM, Nanda R, Hwang ES (2013) Cancer 119: 1776-83 The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up. Sanders ME, Schuyler PA, Dupont WD, Page DL (2005) Cancer 103: 2481-4 A population-based case-control study of fetal growth, gestational age, and maternal breast cancer. Nechuta S, Paneth N, Pathak DR, Gardiner J, Copeland G, Velie EM (2010) Am J Epidemiol 172: 962-70 Vitamin supplement use during breast cancer treatment and survival: a prospective cohort study. Nechuta S, Lu W, Chen Z, Zheng Y, Gu K, Cai H, Zheng W, Shu XO (2011) Cancer Epidemiol Biomarkers Prev 20: 262-71 Heritable variation of ERBB2 and breast cancer risk. Breyer JP, Sanders ME, Airey DC, Cai Q, Yaspan BL, Schuyler PA, Dai Q, Boulos F, Olivares MG, Bradley KM, Gao YT, Page DL, Dupont WD, Zheng W, Smith JR (2009) Cancer Epidemiol Biomarkers Prev 18: 1252-8 The expression of p120ctn protein in breast cancer is independent of alpha- and beta-catenin and E-cadherin. Dillon DA, D'Aquila T, Reynolds AB, Fearon ER, Rimm DL (1998) Am J Pathol 152: 75-82 Anatomic indicators (histologic and cytologic) of increased breast cancer risk. Page DL, Dupont WD (1993) Breast Cancer Res Treat 28: 157-66 p53 mutations are confined to the comedo type ductal carcinoma in situ of the breast. Immunohistochemical and sequencing data. O'Malley FP, Vnencak-Jones CL, Dupont WD, Parl F, Manning S, Page DL (1994) Lab Invest 71: 67-72 Aberrant activation of NF-κB signaling in mammary epithelium leads to abnormal growth and ductal carcinoma in situ. Barham W, Chen L, Tikhomirov O, Onishko H, Gleaves L, Stricker TP, Blackwell TS, Yull FE (2015) BMC Cancer 15: 647 Shutter-speed analysis of contrast reagent bolus-tracking data: Preliminary observations in benign and malignant breast disease. Li X, Huang W, Yankeelov TE, Tudorica A, Rooney WD, Springer CS (2005) Magn Reson Med 53: 724-9 Syndecan-1 overexpression is associated with nonluminal subtypes and poor prognosis in advanced breast cancer. Nguyen TL, Grizzle WE, Zhang K, Hameed O, Siegal GP, Wei S (2013) Am J Clin Pathol 140: 468-74 Development of a spatially offset Raman spectroscopy probe for breast tumor surgical margin evaluation. Keller MD, Vargis E, de Matos Granja N, Wilson RH, Mycek MA, Kelley MC, Mahadevan-Jansen A (2011) J Biomed Opt 16: 077006 Evaluation of dual immunohistochemistry and chromogenic in situ hybridization for HER2 on a single section. Reisenbichler ES, Horton D, Rasco M, Andea A, Hameed O (2012) Am J Clin Pathol 137: 102-10 Loss of expression of transforming growth factor beta type II receptor correlates with high tumour grade in human breast in-situ and invasive carcinomas. Gobbi H, Arteaga CL, Jensen RA, Simpson JF, Dupont WD, Olson SJ, Schuyler PA, Plummer WD, Page DL (2000) Histopathology 36: 168-77 Ductal carcinoma in situ of the breast with apocrine cytology: definition of a borderline category. O'Malley FP, Page DL, Nelson EH, Dupont WD (1994) Hum Pathol 25: 164-8 Incidental atypical proliferative lesions in reduction mammoplasty specimens in patients with a history of breast cancer. Li Z, Fadare O, Hameed O, Zhao C, Desouki MM (2014) Hum Pathol 45: 104-9 Incidental atypical proliferative lesions in reduction mammoplasty specimens: analysis of 2498 cases from 2 tertiary women's health centers. Desouki MM, Li Z, Hameed O, Fadare O, Zhao C (2013) Hum Pathol 44: 1877-81 A new approach to elastography using mutual information and finite elements. Miga MI (2003) Phys Med Biol 48: 467-80 Reproductive windows, genetic loci, and breast cancer risk. Warren Andersen S, Trentham-Dietz A, Gangnon RE, Hampton JM, Figueroa JD, Skinner HG, Engelman CD, Klein BE, Titus LJ, Egan KM, Newcomb PA (2014) Ann Epidemiol 24: 376-82 Autofluorescence and diffuse reflectance spectroscopy and spectral imaging for breast surgical margin analysis. Keller MD, Majumder SK, Kelley MC, Meszoely IM, Boulos FI, Olivares GM, Mahadevan-Jansen A (2010) Lasers Surg Med 42: 15-23 Integration of quantitative DCE-MRI and ADC mapping to monitor treatment response in human breast cancer: initial results. Yankeelov TE, Lepage M, Chakravarthy A, Broome EE, Niermann KJ, Kelley MC, Meszoely I, Mayer IA, Herman CR, McManus K, Price RR, Gore JC (2007) Magn Reson Imaging 25: 1-13 Urinary estrogen metabolites and breast cancer: a combined analysis of individual level data. Dallal CM, Stone RA, Cauley JA, Ness RB, Vogel VG, Fentiman IS, Fowke JH, Krogh V, Loft S, Meilahn EN, Muti P, Olsen A, Overvad K, Sieri S, Tjønneland A, Ursin G, Wellejus A, Taioli E (2013) Int J Biol Markers 28: 3-16 Breast carcinomas with isolated bone metastases have different hormone receptor expression profiles than those with metastases to other sites or multiple organs. Wei S, Li Y, Siegal GP, Hameed O (2011) Ann Diagn Pathol 15: 79-83 Accuracy of intraoperative gross examination of surgical margin status in women undergoing partial mastectomy for breast malignancy. Balch GC, Mithani SK, Simpson JF, Kelley MC (2005) Am Surg 71: 22-7; discussion 27-8 Biopsy needle technique and the accuracy of diagnosis of atypical ductal hyperplasia for mammographic abnormalities. Zhao L, Freimanis R, Bergman S, Shen P, Perrier ND, Lesko N, Pulaski T, Pulaski S, Carr JJ, Levine EA (2003) Am Surg 69: 757-62; discussion 762
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.